Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

NCT04606433 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Hodgkin Lymphoma
Acute Lymphoblastic Leukemia

Interventions

DRUG: GNC-038

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]